The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist

Thrombosis Research

Volumn 81, Issue 4, 1996, Pages 439-450

  Aoki, Toshiaki ^a   Dermot, Cox ^b   Senzaki, Kayoko ^b   Seki, Jiro ^b   Tanaka, Akihito ^b   Takasugi, Hisashi ^b   Motoyama, Yukio ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b NONE

Author keywords

FK633; GPIIb IIIa antagonist; platelet aggregation; thrombosis

Indexed keywords

4 (4 AMIDINOPHENOXY)BUTYRYLASPARTYLVALINE; ANTICOAGULANT AGENT; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; CONTROLLED STUDY; DOG; HUMAN; HUMAN CELL; NONHUMAN; PREVENTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOSIS;

EID: 0343027290     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00016-3     Document Type: Article

References (34)

1. FITZGERALD, D.J., ROY, L., CATELLA, F. AND FITZGERALD, G.A. Platelet activation in unstable coronary disease. N Engl J Med 315, 983-989, 1986.
2. RUBENSTEIN, M.D., WALL, R.T., BAIN, D.S. and HARRISON, D.C. Platelet activation in clinical coronary artery disease and spasm. Am Heart J 102, 363-367, 1981.
3. DAVIES, M.J. AND THOMAS, A.C. Plaque fissuring - the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 53, 363-370, 1985.
4. FUSTER, V. AND CHESEBRO, J.H. Mechanisms of unstable angina. N Engl J Med 315, 1023, 1986.
5. WILLERSON, J.T., HILLIS, L.D., WINNIFORD, M. AND BUJA, L.M. Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes. J Am Coll Cardiol 8, 245, 1986.
6. STEIN, B.S., FUSTER, V., ISRAEL, D.M., COHEN, M., BADIMON, L., BADIMON, J. AND CHESEBRO, J. Platelet inhibitor agents in cardiovascular disease: an update. J Am Coll Cardiol 14(4), 813-836, 1989.
7. COLLER, B.S. Platelets and thrombolytic therapy. N Engl J Med 322, 33-42, 1990.
8. NACHMAN, R.L. AND LEUNG, L.L.K. Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest 69, 263-269, 1982.
9. COOK, N.S., KOTTIRSCH, G. and ZERWES, H.G. Platelet glycoprotein IIb/IIIa antagonist. Drugs Fut 19 (2), 135-159, 1994.
10. RUOSLAHTI, E. Integrins. J Clin Invest 87, 1-5, 1991.
11. PYTELA, R., PIERSCHBACHER, M.S., GINSBURG, M.H., PLOW, E.F. AND RUOSLAHTI, E. Platelet membrane glycoprotein IIb/IIIa: member of a family of RGD specific adhesion receptors. Science 231, 1559-1562, 1986.
12. PLOW, E.F., PIERSCHBACHER, M.D., RUOSLAHTI, E., MARGUERIE, G. AND GINSBURG, M.H. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 82, 8057-8061, 1985.
13. BHATTACHARYA, S., MACHIN, S.J. AND LAHIRI, A. Therapeutic implications of a specific murine monoclonal antibody(7E3) to the platelet receptor GPIIb/IIIa. Platelets 3, 119,1992.
14. KLEIMAN, N.S., OHMAN, E.M., CALIFF, R.M. et al. Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the thrombolysis and angioplasty in myocardial infarction (TAMI) 8 pilot study. J Am Coll Cardiol 22, 381-389, 1993.
15. SIMOONS, M.L., VAN DER BRAND, M., HOORNTJE, J.C.A., et al. Chimeric 7E3 antiplatelet antibody Fab for the treatment of refractory unstable angina: A placebo-controlled pilot study. J Amer Coll Cardiol 21, 269A, 1992.
16. EPIC INVESTIGATORS. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty: N Eng J Med 330, 956-961, 1994.
17. YATOGO, T., IZUMI, E., KAWAGUTI, H. AND HAYASHI, M. Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Structure and Function 73, 281-292, 1988.
18. 131I-labele d human growth hormone of highly specific radioactivity. Biochem J 89, 114-123, 1963.
19. TUSXYNSKI, G., KNIGHT, L. AND PIPERINO, J. Removal of free radioiodide from solution of radiolabelled protein by rapid centrifugation technique. J Labeled Compounds and Radiopharmaceutical XVIII(1-2), 206-207, 1981.
20. COX, D., MOTOYAMA, Y., SEKI, J., AOKI, T., DOHI, M. AND YOSHIDA, K. Pentamidine: A non-peptide GP IIb/IIIa antagonist - In vitro studies on platelets from humans and other species. Thromb Haemost 68, 731-736, 1992.
21. CONNOLLY, D.T., NNIGHT, M.B., HARAKAS, N.K., WITTWER, A.J. AND FEDER, J. Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem 152, 136-140, 1986.
22. FOLTS, D.J. Experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance. Cardiovasc Rev Rep 3, 370-382, 1982.
23. ALBELDA, S.M., DAISE, M., LEVINE, E.M. AND BUCH, C.A. Identification and characterization of cell-substratum adhesion receptor on cultured human endothelial cells. J Clin Invest 83, 1992-2002, 1989.
24. CHEN, C.S. AND HAWIGER, J. Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix. Blood 77, 2200-2206, 1991.
25. v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 265, 5938-5941, 1990.
26. HUBER, R. AND BODE, W. Structural basis of the activation and action of trypsin. Acc Chem Res 77, 114-122, 1978.
27. ASHBY, B., DANIEL, J.L. AND SMITH, J.B. Mechanisms of platelet activation and inhibition. Platelet Health Dis 4, 1-26, 1990.
28. 2 and serotonin after thrombolysis with t-PA in a canine preparation of coronary thrombosis. Circulation 77, 678-684, 1988.
29. PATRONO, C. Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and block. Trends Pharmacol Sci 10, 453-458, 1989.
30. SALTIEL, E. AND WART, A. Ticlopidine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in platelet-dependent disease states. Drugs 34, 222-262, 1987.
31. HERSHKOVIZ, R., GREENSPOON, N., MEKORI, Y.A., ALON, R., KAPUSTINA, G. AND LIDER, O. Inhibition of CD4+ T lymphocyte binding to fibronectin and immune-cell accumulation in inflammatory sites by non-peptidic mimetics of Arg-Gly-Asp. Clin Exp Immunol 95, 270-216, 1994.
32. HERSHKOVIZ, R., MELAMED, S., GREENSPOON, N. AND LIDER, O. Nonpepditic analogues of the Arg-Gly-Asp (RGD) sequence specifically inhibit the adhesion of human tenon's capsule fibroblasts to fibronectin. Invest Ophthalmol Vis Sci 35, 2585-2591, 1994.
33. TSCHOPP, J.F., CURT, M., KENNETH, G., RAYMOND, C. AND MIHAEL, D.P. Inhibition of thrombosis by a selestive fibrinogen receptor antagonist without effect on bleeding time. Thromb Hemost 72(1), 119-124, 1994.
34. FRELINGER, A.L.III., LAM, S.C.T., PLOW, E.F., SMITH, M.A. LOFTUS, J.C. AND GINSBERG, M.H. Occupancy of an adhesive glycoprotein receptor modulates expression of an antigenic site involved in cell adhesion. J Biol Chem 263(25), 12397-12402, 1988.